ZEISS VISULAS Combi is an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp ...
DORC’s ILM-Blue receives China NMPA approval; expanding global reach to prove high-quality and effective solutions to ophthalmic community: Jena, Germany Saturday, March 29, 202 ...
Zeiss has introduced a new artificial intelligence (AI) guided image assessment tool for the Cirrus optical coherence tomography (OCT) device. At 100% Optical (1–3 March), the company demonstrated the ...
JENA, Germany, March 27, 2025 /CNW/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue ® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received ...
Zeiss Vision will remain dedicated to its investment in China, one of the top priority markets for the German manufacturer of eyeglass lenses and ophthalmic instruments, a senior executive of the ...
Head of Strategic Business Unit Ophthalmology, President ZEISS Ophthalmology. Dr. Jørn S. Jørgensen added, “We have seen a rising trend of presbyopia in mainland China, Hong Kong, and globally.
To date, ILM-Blue ® remains the only ILM staining solution approved by the FDA. It is marketed under the brand name ...
JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue ® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results